van Unen L - Search Results

1

Prospects of TAT-mediated protein therapy for fragile X syndrome.

Reis SA, Willemsen R, van Unen L, Hoogeveen AT, Oostra BA. Reis SA, et al. Among authors: van unen l. J Mol Histol. 2004 May;35(4):389-95. doi: 10.1023/b:hijo.0000039841.22959.3c. J Mol Histol. 2004. PMID: 15503812

2

Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis.

Tamanini F, Willemsen R, van Unen L, Bontekoe C, Galjaard H, Oostra BA, Hoogeveen AT. Tamanini F, et al. Among authors: van unen l. Hum Mol Genet. 1997 Aug;6(8):1315-22. doi: 10.1093/hmg/6.8.1315. Hum Mol Genet. 1997. PMID: 9259278 Free article.

3

Different targets for the fragile X-related proteins revealed by their distinct nuclear localizations.

Tamanini F, Bontekoe C, Bakker CE, van Unen L, Anar B, Willemsen R, Yoshida M, Galjaard H, Oostra BA, Hoogeveen AT. Tamanini F, et al. Among authors: van unen l. Hum Mol Genet. 1999 May;8(5):863-9. doi: 10.1093/hmg/8.5.863. Hum Mol Genet. 1999. PMID: 10196376 Free article.

4

Oligomerization properties of fragile-X mental-retardation protein (FMRP) and the fragile-X-related proteins FXR1P and FXR2P.

Tamanini F, Van Unen L, Bakker C, Sacchi N, Galjaard H, Oostra BA, Hoogeveen AT. Tamanini F, et al. Among authors: van unen l. Biochem J. 1999 Nov 1;343 Pt 3(Pt 3):517-23. Biochem J. 1999. PMID: 10527928 Free PMC article.

5

The fragile X-related proteins FXR1P and FXR2P contain a functional nucleolar-targeting signal equivalent to the HIV-1 regulatory proteins.

Tamanini F, Kirkpatrick LL, Schonkeren J, van Unen L, Bontekoe C, Bakker C, Nelson DL, Galjaard H, Oostra BA, Hoogeveen AT. Tamanini F, et al. Among authors: van unen l. Hum Mol Genet. 2000 Jun 12;9(10):1487-93. doi: 10.1093/hmg/9.10.1487. Hum Mol Genet. 2000. PMID: 10888599 Free article.

6

The transcriptional corepressor MTG16a contains a novel nucleolar targeting sequence deranged in t (16; 21)-positive myeloid malignancies.

Hoogeveen AT, Rossetti S, Stoyanova V, Schonkeren J, Fenaroli A, Schiaffonati L, van Unen L, Sacchi N. Hoogeveen AT, et al. Among authors: van unen l. Oncogene. 2002 Sep 26;21(43):6703-12. doi: 10.1038/sj.onc.1205882. Oncogene. 2002. PMID: 12242670

7

The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome.

Willemsen R, Hoogeveen-Westerveld M, Reis S, Holstege J, Severijnen LA, Nieuwenhuizen IM, Schrier M, van Unen L, Tassone F, Hoogeveen AT, Hagerman PJ, Mientjes EJ, Oostra BA. Willemsen R, et al. Among authors: van unen l. Hum Mol Genet. 2003 May 1;12(9):949-59. doi: 10.1093/hmg/ddg114. Hum Mol Genet. 2003. PMID: 12700164 Free article.

8

Loss of FMR1 hypermethylation in somatic cell heterokaryons.

Stoyanova V, Rossetti S, VAN Unen L, Oostra BA, Hoogeveen AT. Stoyanova V, et al. Among authors: van unen l. FASEB J. 2004 Dec;18(15):1964-6. doi: 10.1096/fj.04-2499fje. Epub 2004 Sep 17. FASEB J. 2004. PMID: 15377638

9

Myeloid maturation block by AML1-MTG16 is associated with Csf1r epigenetic downregulation.

Rossetti S, Van Unen L, Touw IP, Hoogeveen AT, Sacchi N. Rossetti S, et al. Among authors: van unen l. Oncogene. 2005 Aug 11;24(34):5325-32. doi: 10.1038/sj.onc.1208651. Oncogene. 2005. PMID: 16007222

10

Novel RNA-binding properties of the MTG chromatin regulatory proteins.

Rossetti S, van Unen L, Sacchi N, Hoogeveen AT. Rossetti S, et al. Among authors: van unen l. BMC Mol Biol. 2008 Oct 24;9:93. doi: 10.1186/1471-2199-9-93. BMC Mol Biol. 2008. PMID: 18950503 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters